Sario Angel Chamorro Quijano
ABSTRACT
This research analyzes how exogenous factors (EF) influence the complications of Systemic Lupus Erythematosus by region in Peru (Costa, Sierra and Selva). Three studies are presented: The first study determines how EF complicates the clinical manifestations in patients diagnosed with SLE in each region. In the second study the most common and susceptible diseases related to lupus are compared through medical reports by region, in the third study clinical histories of patients with Systemic Lupus Erythematosus (SLE) from Costa, Sierra and Selva are taken, which in turn presented complications specific to your region, analyzing and comparing if it is related. The results indicate that it is not related, since each region presents its own EF such as climate, diet, m.a.s.l., radiation, which influence the evolution, prognosis and complication of the disease, it should be noted that in each region there are a different Complication in the case of the mountains, the clinical picture of the patient was SLE + SEROSITIS, in the case of the jungle the clinical picture of the patient SLE + TUBERCULOSIS, finally on the coast they presented SLE + SKIN DISEASES, the cause being mortality due to SLE but the complication associated with it according to the region.
Supplemental Material
Available for Download
Presentation slides
- Narváez, J. 2020. Systemic lupus erythematosus 2020. Medicina Clinica. 155, 11 (Dec. 2020), 494–501. DOI:https://doi.org/10.1016/j.medcli.2020.05.009.Google Scholar
Cross Ref
- Pan American Health Organization. (2017). Health in the Americas+: Summary: Regional Outlook and Country Profiles. Pan American Health Organization.Google Scholar
- Naghavi, M. 2015. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 385, 9963 (2015), 117–171. DOI:https://doi.org/10.1016/S0140-6736(14)61682-2.Google ScholarCross Ref
- Bvs.minsa.gob.pe, 2011. [Online]. Available: http://bvs.minsa.gob.pe/local/MINSA/3652.pdf.Google Scholar
- Yamamoto, A.L.C. 2018. Validation and analysis of UV radiation time series collected in different peruvian sites. Revista Brasileira de Meteorologia. 33, 2 (2018), 298–305. DOI:https://doi.org/10.1590/0102-7786332011Google ScholarCross Ref
- Piazena, H. and Kelleher, D.K. 2010. Effects of infrared-A irradiation on skin: discrepancies in published data highlight the need for an exact consideration of physical and photobiological laws and appropriate experimental settings. Photochemistry and Photobiology. 86, 3 (Jun. 2010), 687–705. DOI:https://doi.org/10.1111/j.1751-1097.2010.00729.x.Google ScholarCross Ref
- Kelly, G.S. 2007. Body temperature variability (Part 2): masking influences of body temperature variability and a review of body temperature variability in disease. Alternative Medicine Review: A Journal of Clinical Therapeutic. 12, 1 (Mar. 2007), 49–62.Google Scholar
- Cayllahua MG., “Lupus Eritematoso Sistémico En El Hospital Daniel Alcides Carrión Huancayo [dissertation]. Huancayo (PE): Universidad Nacional Del Centro Del Perú;,” p. 57, 2016.Google Scholar
- Mora C, Segami M. Pronóstico de los pacientes con lupus eritematoso sistémico admitidos a la unidad de cuidados intensivos del HNERM, Lima. Rev. Perú Reuma. 2003;9(2):57-9.Google Scholar
- Lyon, S.M. and Rossman, M.D. 2017. Pulmonary Tuberculosis. Microbiology Spectrum. 5, 1 (Jan. 2017). DOI:https://doi.org/10.1128/microbiolspec.TNMI7-0032-2016. [11] E. S. Estudio, “Tuberculosis en pacientes peruanos con Lupus,” vol. 18, no. 1, pp. 5–10, 2004.Google ScholarCross Ref
- Gergianaki, I. 2018. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Practice & Research. Clinical Rheumatology. 32, 2 (Apr. 2018), 188–205. DOI:https://doi.org/10.1016/j.berh.2018.09.004.Google ScholarCross Ref
- Andrade L., “Características Clínico Epidemiológicas de la Tuberculosis en pacientes con Lupus Eritematoso Sistémico Hospital Nacional Dos de Mayo,” vol. 11, pp. 13–29, 2005.Google Scholar
- Massaro, M.G. 2020. Therapeutic management of idiopathic recurrent serositis: a retrospective study. European Review for Medical and Pharmacological Sciences. 24, 6 (Mar. 2020), 3352–3359. DOI:https://doi.org/10.26355/eurrev_202003_20703.Google ScholarCross Ref
- Karpathiou, G. 2019. Non-specific pleuritis: pathological patterns in benign pleuritis. Pathology. 51, 4 (Jun. 2019), 405–411. DOI:https://doi.org/10.1016/j.pathol.2019.01.007.).Google ScholarCross Ref
- Chiabrando, J.G. 2020. Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 75, 1 (Jan. 2020), 76–92. DOI:https://doi.org/10.1016/j.jacc.2019.11.021.Google ScholarCross Ref
- Stojan, G. 2020. A Spatiotemporal Analysis of Organ-Specific Lupus Flares in Relation to Atmospheric Variables and Fine Particulate Matter Pollution. Arthritis & Rheumatology (Hoboken, N.J.). 72, 7 (Jul. 2020), 1134–1142. DOI:https://doi.org/10.1002/art.41217.Google ScholarCross Ref
- Alves, A.G.F. 2018. Influence of air pollution on airway inflammation and disease activity in childhood-systemic lupus erythematosus. Clinical Rheumatology. 37, 3 (Mar. 2018), 683–690. DOI:https://doi.org/10.1007/s10067-017-3893-1.Google ScholarCross Ref
- Chuquihuara B., "Manifestaciones clínicas de pacientes con lupus eritematoso sistémico al inicio y durante su evolución atendidos en el Hospital Nacional Dos de Mayo, 2000 – 2017", Licenciatura, Universidad Nacional Mayor de San Marcos, 2019.Google Scholar
Recommendations
Latent class model based diagnostic system utilizing traditional Chinese medicine for patients with systemic lupus erythematosus
Systemic lupus erythematosus (SLE) can affect nearly any organ system, and is frequently an evolving disease with varied manifestations. Traditional Chinese medicine (TCM) physicians have identified different SLE patterns that they have difficulty ...
Comments